On the public citation graph
The Mutational Landscape of Homologous Recombination Repair (Hrr) Genes and Their Impacts on Metastatic Colorectal Cancer Patients Treated With Immunotherapy
0 signed · 50 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.ajhg.2018.01.018openalex-extracted
Inherited DNA-Repair Defects in Colorectal Cancer
inferredcites →https://doi.org/10.1016/j.annonc.2020.06.004openalex-extracted
The forefront of ovarian cancer therapy: update on PARP inhibitors
inferredcites →https://doi.org/10.1016/j.apsb.2021.01.003openalex-extracted
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.cell.2017.01.002openalex-extracted
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
inferredcites →https://doi.org/10.1016/j.celrep.2018.03.076openalex-extracted
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
inferredcites →https://doi.org/10.1016/j.jmoldx.2019.06.011openalex-extracted
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples
inferredcites →https://doi.org/10.1016/j.molcel.2020.07.026openalex-extracted
DNA Damage and Cancer Immunotherapy: A STING in the Tale
inferredcites →https://doi.org/10.1016/j.tranon.2020.100986openalex-extracted
Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer
inferredcites →https://doi.org/10.1016/j.ygyno.2019.02.011openalex-extracted
Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma
inferredcites →https://doi.org/10.1038/nrclinonc.2018.29openalex-extracted
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
inferredcites →https://doi.org/10.1038/s41388-019-0733-6openalex-extracted
Base excision repair regulates PD-L1 expression in cancer cells
inferredcites →https://doi.org/10.1038/s41416-018-0274-8openalex-extracted
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
inferredcites →https://doi.org/10.1038/s41467-017-01883-9openalex-extracted
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
inferredcites →https://doi.org/10.1038/s41571-021-00496-yopenalex-extracted
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
inferredcites →https://doi.org/10.1038/s41698-023-00442-4openalex-extracted
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays
inferredcites →https://doi.org/10.1053/j.gastro.2009.12.064openalex-extracted
Microsatellite Instability in Colorectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa1706450openalex-extracted
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
inferredcites →https://doi.org/10.1056/nejmoa1903387openalex-extracted
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
inferredcites →https://doi.org/10.1056/nejmoa1911361openalex-extracted
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
inferredcites →https://doi.org/10.1056/nejmoa1911440openalex-extracted
Olaparib for Metastatic Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1056/nejmoa2017699openalex-extracted
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
inferredcites →https://doi.org/10.1080/21655979.2021.1964156openalex-extracted
RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway
inferredcites →https://doi.org/10.1093/annonc/mdz134openalex-extracted
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
inferredcites →https://doi.org/10.1093/jnci/djab169openalex-extracted
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
inferredcites →https://doi.org/10.1101/gr.239244.118openalex-extracted
Maftools: efficient and comprehensive analysis of somatic variants in cancer
inferredcites →https://doi.org/10.1136/jitc-2021-002336openalex-extracted
Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers
inferredcites →https://doi.org/10.1158/0008-5472.can-15-2361openalex-extracted
Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-2477openalex-extracted
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-19-3529openalex-extracted
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-20-3635openalex-extracted
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
inferredcites →https://doi.org/10.1172/jci139333openalex-extracted
ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation
inferredcites →https://doi.org/10.1186/s12916-022-02327-yopenalex-extracted
Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma
inferredcites →https://doi.org/10.1186/s12943-023-01827-6openalex-extracted
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
inferredcites →https://doi.org/10.1186/s13046-020-01811-8openalex-extracted
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer
inferredcites →https://doi.org/10.1186/s13073-017-0424-2openalex-extracted
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
inferredcites →https://doi.org/10.1186/s13073-019-0620-3openalex-extracted
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
inferredcites →https://doi.org/10.1186/s13073-019-0631-0openalex-extracted
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
inferredcites →https://doi.org/10.1186/s40425-018-0463-2openalex-extracted
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
inferredcites →https://doi.org/10.1186/s40880-019-0379-3openalex-extracted
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
inferredcites →https://doi.org/10.1200/po.17.00286openalex-extracted
Prevalence of Homologous Recombination–Related Gene Mutations Across Multiple Cancer Types
inferredcites →https://doi.org/10.18632/aging.202267openalex-extracted
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses
inferredcites →https://doi.org/10.18632/aging.203670openalex-extracted
Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort
inferredcites →https://doi.org/10.18632/oncotarget.7277openalex-extracted
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
inferredcites →https://doi.org/10.3322/caac.21492openalex-extracted
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
inferredcites →https://doi.org/10.3322/caac.21660openalex-extracted
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
inferredcites →https://doi.org/10.3322/caac.21731openalex-extracted
Cancer treatment and survivorship statistics, 2022
inferredcites →https://doi.org/10.3389/fimmu.2022.871756openalex-extracted
Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma
inferredcites →https://doi.org/10.4143/crt.2020.798openalex-extracted
Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
inferredcites →https://doi.org/10.6004/jnccn.2017.0016openalex-extracted
Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring aPOLEMutation
inferredcites →https://doi.org/10.1101/cshperspect.a012633openalex-snapshot
Postreplicative Mismatch Repair
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.